NO994078L - Forbindelser for inhibisjon av mavesyresekresjon - Google Patents

Forbindelser for inhibisjon av mavesyresekresjon

Info

Publication number
NO994078L
NO994078L NO994078A NO994078A NO994078L NO 994078 L NO994078 L NO 994078L NO 994078 A NO994078 A NO 994078A NO 994078 A NO994078 A NO 994078A NO 994078 L NO994078 L NO 994078L
Authority
NO
Norway
Prior art keywords
inhibition
compounds
gastric acid
acid secretion
secretion
Prior art date
Application number
NO994078A
Other languages
English (en)
Other versions
NO994078D0 (no
NO313009B1 (no
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO994078D0 publication Critical patent/NO994078D0/no
Publication of NO994078L publication Critical patent/NO994078L/no
Publication of NO313009B1 publication Critical patent/NO313009B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19994078A 1997-02-25 1999-08-24 Forbindelser for inhibering av mavesyresekresjon, farmasöytisk formulering inneholdende slike forbindelser, deresanvendelse og fremgangsmåte for deres fremstilling NO313009B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds
PCT/SE1998/000275 WO1998037080A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion

Publications (3)

Publication Number Publication Date
NO994078D0 NO994078D0 (no) 1999-08-24
NO994078L true NO994078L (no) 1999-08-24
NO313009B1 NO313009B1 (no) 2002-07-29

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994078A NO313009B1 (no) 1997-02-25 1999-08-24 Forbindelser for inhibering av mavesyresekresjon, farmasöytisk formulering inneholdende slike forbindelser, deresanvendelse og fremgangsmåte for deres fremstilling

Country Status (33)

Country Link
US (1) US6265415B1 (no)
EP (1) EP0971920B1 (no)
JP (1) JP2001512477A (no)
KR (1) KR20000075622A (no)
CN (1) CN1100056C (no)
AR (1) AR011134A1 (no)
AT (1) ATE218569T1 (no)
AU (1) AU723389B2 (no)
BR (1) BR9807457A (no)
CA (1) CA2280008A1 (no)
CZ (1) CZ291681B6 (no)
DE (1) DE69805787T2 (no)
DK (1) DK0971920T3 (no)
EE (1) EE04016B1 (no)
ES (1) ES2178169T3 (no)
HK (1) HK1024248A1 (no)
HU (1) HUP0000720A3 (no)
ID (1) ID22218A (no)
IL (1) IL131122A0 (no)
IS (1) IS1901B (no)
MY (1) MY118822A (no)
NO (1) NO313009B1 (no)
NZ (1) NZ336878A (no)
PL (1) PL190379B1 (no)
PT (1) PT971920E (no)
RU (1) RU2193036C2 (no)
SE (1) SE9700661D0 (no)
SK (1) SK283903B6 (no)
TR (1) TR199902060T2 (no)
TW (1) TW568907B (no)
UA (1) UA64741C2 (no)
WO (1) WO1998037080A1 (no)
ZA (1) ZA981134B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014084312A1 (ja) * 2012-11-30 2014-06-05 アステラス製薬株式会社 イミダゾピリジン化合物

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
DE69529219T2 (de) * 1994-07-01 2003-11-06 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Helicobacter proteine und impstoffe
WO1997025429A1 (en) * 1996-01-04 1997-07-17 Rican Limited Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) * 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
CA2458854A1 (en) * 2001-08-31 2003-03-06 Chiron Srl Helicobacter pylori vaccination
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
TWI351405B (en) 2002-09-19 2011-11-01 Schering Corp Novel imidazopyridines as cyclin dependent kinase
DK1603570T5 (da) 2003-02-26 2013-12-09 Sugen Inc Aminoheteroarylforbindelser som proteinkinaseinhibitorer
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
EP1670795A1 (en) * 2003-09-18 2006-06-21 ALTANA Pharma AG Pharmacologically active imidazo 4,5-c pyridines
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
KR102152809B1 (ko) * 2004-07-28 2020-09-07 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-ｃ〕피리딘 화합물, 그 제조 방법 및 용도
CA2579087C (en) 2004-09-03 2012-05-01 Yuhan Corporation Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
KR100958828B1 (ko) 2004-09-03 2010-05-24 주식회사유한양행 피롤로[3,2-ｂ]피리딘 유도체 및 그의 제조방법
WO2006025714A1 (en) 2004-09-03 2006-03-09 Yuhan Corporation PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
TW200700064A (en) * 2005-03-24 2007-01-01 Glaxo Group Ltd Novel compounds
AU2006323025B2 (en) 2005-12-05 2012-07-05 Pfizer Products Inc. Polymorphs of a c-Met/HGFR inhibitor
PL1959955T3 (pl) 2005-12-05 2011-04-29 Pfizer Prod Inc Sposób traktowania nieprawidłowego wzrostu komórek
RU2608611C2 (ru) * 2009-11-05 2017-01-23 Юниверсити Оф Нотр Дам Дю Лак СОЕДИНЕНИЯ ИМИДАЗО[1,2-а] ПИРИДИНА, ИХ СИНТЕЗ И СПОСОБЫ ПРИМЕНЕНИЯ
ES2597034T3 (es) 2011-05-30 2017-01-13 Astellas Pharma Inc. Compuesto de imidazopiridina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014084312A1 (ja) * 2012-11-30 2014-06-05 アステラス製薬株式会社 イミダゾピリジン化合物

Also Published As

Publication number Publication date
KR20000075622A (ko) 2000-12-26
TW568907B (en) 2004-01-01
ES2178169T3 (es) 2002-12-16
CA2280008A1 (en) 1998-08-27
SK109999A3 (en) 2000-01-18
PT971920E (pt) 2002-11-29
SK283903B6 (sk) 2004-04-06
ATE218569T1 (de) 2002-06-15
DE69805787T2 (de) 2003-01-02
PL190379B1 (pl) 2005-12-30
HUP0000720A3 (en) 2001-01-29
HUP0000720A2 (hu) 2000-10-28
JP2001512477A (ja) 2001-08-21
EE9900367A (et) 2000-04-17
AU723389B2 (en) 2000-08-24
CN1100056C (zh) 2003-01-29
CN1248257A (zh) 2000-03-22
DE69805787D1 (de) 2002-07-11
AR011134A1 (es) 2000-08-02
DK0971920T3 (da) 2002-09-16
IS1901B (is) 2003-11-20
IL131122A0 (en) 2001-01-28
BR9807457A (pt) 2000-04-25
UA64741C2 (uk) 2004-03-15
RU2193036C2 (ru) 2002-11-20
EP0971920A1 (en) 2000-01-19
MX9907650A (es) 2002-12-13
EP0971920B1 (en) 2002-06-05
MY118822A (en) 2005-01-31
WO1998037080A1 (en) 1998-08-27
NZ336878A (en) 2001-05-25
NO994078D0 (no) 1999-08-24
CZ291681B6 (cs) 2003-04-16
HK1024248A1 (en) 2000-10-05
IS5148A (is) 1999-08-05
SE9700661D0 (sv) 1997-02-25
CZ301499A3 (cs) 2000-02-16
NO313009B1 (no) 2002-07-29
ID22218A (id) 1999-09-16
TR199902060T2 (xx) 2000-02-21
EE04016B1 (et) 2003-04-15
ZA981134B (en) 1998-08-25
PL335485A1 (en) 2000-04-25
US6265415B1 (en) 2001-07-24
AU6314798A (en) 1998-09-09

Similar Documents

Publication Publication Date Title
NO994078L (no) Forbindelser for inhibisjon av mavesyresekresjon
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO20001728D0 (no) Fremgangsmåte for fremstilling av chirale forbindelser
NO20004288D0 (no) FremgangsmÕte til fremstilling av et beskyttet 4-aminometyl- pyrrolidin-3-on
NO993949L (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
NO20062796L (no) Fremgangsmate for fremstilling av en dihydroksyaminoforbindelse
GB2355657B (en) Inhibitors Of Gastric Acid Secretion
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO983784L (no) Fremgangsmåter for fremstilling av bifenyl-isoksasolsulfonamider
ID24327A (id) Produksi senyawa-senyawa avermektin
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
NO994131D0 (no) Fremgangsmåte for fremstilling av benzotiazolonforbindelser
NO972529D0 (no) Forbindelse for inhibering av mavesyresekresjon
FI981803A0 (fi) Menetelmä saostumien muodostumisen estämiseksi
FI972694A0 (fi) Uusi menetelmä sameridiinin valmistamiseksi
SI0971920T1 (en) Compounds for inhibition of gastric acid secretion
NO994793L (no) Fremgangsmåte for fremstilling av clavulansyre
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler
FI971913A0 (fi) Foerfarande foer oekning av en nedkylningsapparaturs nedkylningseffekt i en ishall
NO920033L (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser